Previous Quote Previous Quote

Jennifer A. Doudna Quotes

Next Quote Next Quote
Image of the quote is loading... SaveSave As we began discussing authorship of a white paper summarizing our conclusions, we debated who our target audience should be and what kind of outcome we were hoping to achieve. - Quote by Jennifer A. Doudna

As we began discussing authorship of a white paper summarizing our conclusions, we debated who our target audience should be and what kind of outcome we were hoping to achieve.

Jennifer A. Doudna
Copy LinkCopy Link
Copy QuoteCopy Quote
Copy ImageCopy Image
Download Image of QuoteDownload Image

About The Quote

Related Authors

Related Topics

More Quotes From Jennifer A. Doudna

It’s not that I was categorically opposed to the idea of scientists and physicians using gene editing to introduce heritable changes into the human genome.
Jennifer A. Doudna
have no doubt, this technology will — someday, somewhere — be used to change the genome of our own species in ways that are heritable, forever altering the genetic composition of human kind.
Jennifer A. Doudna
in 2011, Rachel and I founded a company called Caribou Biosciences to commercialize the Cas proteins.
Jennifer A. Doudna
Editas Medicine has an exclusive multimillion-dollar license with Juno Therapeutics to develop T cell therapies
Jennifer A. Doudna
PGD has also been used for other controversial purposes, such as the birth if so-called savior siblings, destined from the moment of implantation not only to live their own lives, but also to serve as organ or cell donors for a sibling.
Jennifer A. Doudna
we founded Editas Medicine with $43 million in financing from three venture capital firms.
Jennifer A. Doudna
Report Quote Report Quote Report Quote Submit Quote Submit Quote Submit Quote